Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Monday, October 9, 2023
  • 7:00 AM - 2:00 PM EDT
    Registration
  • 7:15 AM - 8:15 AM EDT
    Breakfast Coffee & Tea
  • 8:15 AM - 9:55 AM EDT
    Session 8: Richter's Transformation - From Biology to Clinic
    Co-Chair: Inhye E. Ahn, MD – Dana-Farber Cancer Institute
    Co-Chair: Lili Wang, MD, PhD – Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia; Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope Comprehensive Cancer Center
  • 9:55 AM - 10:15 AM EDT
    Morning Break
  • 10:15 AM - 11:35 AM EDT
    Session 9: Immunodeficiency and Infections in Patients with CLL
    Co-Chair: Carsten Utoft Niemann, MD, PhD – Department of Hematology, Copenhagen University Hospital Rigshospitalet, Denmark; Hematology Research Group, Danish Cancer Institute Research Center, Denmark; Department of Clinical Medicine, Copenhagen University
    Co-Chair: Clare Sun, MD – Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
  • 11:35 AM - 12:35 PM EDT
    Industry Supported Symposium: Ibrutinib for the Frontline Management of Patients with Chronic Lymphocytic Leukemia (CLL)
  • 12:35 PM - 1:25 PM EDT
    Lunch
  • 1:25 PM - 1:55 PM EDT
    Keynote: Anticipated Role of AI/Machine Learning in Research and Treatment of CLL and Other Malignancies
    Keynote Speaker: Mihaela van der Schaar, PhD – University of Cambridge; The Alan Turing Institute
    Speaker: Jennifer R. Brown, MD, PhD – Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)
    Speaker: Carsten Utoft Niemann, MD, PhD – Department of Hematology, Copenhagen University Hospital Rigshospitalet, Denmark; Hematology Research Group, Danish Cancer Institute Research Center, Denmark; Department of Clinical Medicine, Copenhagen University
  • 1:55 PM - 3:25 PM EDT
    Session 10: Global Perspective on CLL Management - Real World Data and Patient Experiences
    Co-Chair: Anna Schuh, MD, PhD, FRCP, FRCPath – Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford
    Co-Chair: Geoffrey M. Cook – The Max Foundation
  • 3:25 PM - 3:50 PM EDT
    Afternoon Break
  • 3:50 PM - 5:10 PM EDT
    Session 11: Past, Present, and Future of CLL
    Co-Chair: Jennifer R. Brown, MD, PhD – Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)